Tech companies gain favor of Congress in bid to relax regulations

Laura Pedulli | | Health Exec | Digital Transformation

A lobbying campaign by technology companies that will profit from selling digital health has been successful so far, reports Politico.

In the past few weeks, the FDA has promised not to regulate technologies that receive, transmit, store or display data from medical devices, while indicating that it will not regulate most low-risk mobile apps, according to the story.

Read more below:

Despite FDA moves, push continues for Congress to act on mobile health

Laura Pedulli

Related Content

Generative AI isn’t changing everything for patients and providers—but it’s not leaving much unaffected, either
Antibiotics prescriptions: There’s a large-language model for that
4 important AMA insights into physician thinking on, behavior with healthcare AI
Global consortium: The future of AI in healthcare is dynamic—and demanding
Healthcare systems are proceeding apace with GenAI—and learning as they go
To prepare tomorrow’s doctors for evidence-based medicine, instruct today’s med students in dHealth and AI

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”